NEWS


Request for Postdoctoral Applications in Rheumatic and Musculoskeletal Diseases Research. Click here for information


Request for Predoctoral Applications in Rheumatic and Musculoskeletal Diseases Research. Click here for information


UAB 2016 Microbiome Resource Workshop
Save the Date:
September 14 - 15, 2016


UAB REACT aims to catalyze high-impact clinical trials in medical rehabilitation. CAMBAC members Drs. Bamman, Bridges, Saag, McGwin, McLain, Standaert, Cutter and Curtis are members of the REACT Center Executive Leadership team. Click here for information


Technology improves clinical trial management and patient experience


Kenneth G. Saag, M.D., Jane Knight Lowe Professor of Medicine, has been elected president of the Board of Trustees of the National Osteoporosis Foundation.


Mohamed Khass, PhD, Peter Burrows, PhD and Harry W. Schroeder, Jr., MD, PhD discover  checkpoint in B cell development with possible implications on vaccine potency


UAB researcher receives funding for rheumatology study


An $1.8 million Department of Defense grant just awarded to S. Louis Bridges, JR, MD, PhD and Chander Raman, Ph.D., to uncover molecular changes explaining how rheumatoid arthritis leads to joint damage. For details, click here.


The 2015 CAMBAC Research Day


UAB researchers, led by CAMBAC member David Standaert, M.D., Ph.D., professor and chair of the UAB Department of Neurology, show that a microRNA is involved in early Parkinson’s disease pathogenesis. Click here for more


Archived News Stories


 


CAMBAC Research Day - 2015

 

Goals of the Center

  • To generate new understanding of the mechanisms of arthritis, musculoskeletal, bone, and autoimmune diseases and apply this knowledge to improve the diagnosis, treatment, and prevention of these conditions.
  •  

  • To promote and integrate fundamental, translational, and clinical research with clinical care of patients with arthritis, musculoskeletal, bone, and autoimmune diseases.
  •  

  • To educate the public about arthritis, musculoskeletal, bone, and autoimmune diseases and how they can partner with us to achieve our goals of better ways to diagnose, treat, and prevent these conditions.
  •  

  • To train future investigators and health care professionals in arthritis, musculoskeletal, bone, and autoimmune diseases.